Viral load (VL) suppression represents a key to the end of the global HIV epidemic. It is critical for healthcare providers and people living with HIV (PLHIV) to be able to predict viral suppression. Machine learning (ML) is being used in the medical field, for example, to predict patient outcome. This study was conducted to explore the possibility of predicting viral suppression among HIV patients. Anonymized data were used from a cohort of HIV patients managed in eight health facilities supported by MSF in Conakry (Guinea). The data pre-processing steps included variable recoding, record removal, missing values imputation, grouping small categories, creating dummy variables and oversampling (only applied to the training set) of the small...
Objective: To develop an algorithm for optimal use of viral load testing in patients with suspected ...
Introduction:The objective of the study was to develop machine learning (ML) models that predict the...
Infections with the human immunodeficiency virus type 1 (HIV-1) are treated with combinations of dr...
BACKGROUND: The extreme flexibility of the HIV type-1 (HIV-1) genome makes it challenging to build t...
Background: Selecting the optimal combination of HIV drugs for an individual in resourcelimited sett...
BACKGROUND: The extreme flexibility of the HIV type-1 (HIV-1) genome makes it challenging to build ...
Abstract Background Treatment with effective antiretroviral therapy (ART) lowers morbidity and morta...
HIV treatment programs face challenges in identifying patients at risk for loss-to-follow-up and un...
This work shows the application of machine learning to predict current CD4 cell count of an HIV-posi...
Genotypic HIV drug-resistance testing is typically 6065 predictive of response to combination antire...
HIV viral load suppression (VLS) is the most important indicator of successful antiretroviral therap...
OBJECTIVE: To develop an algorithm for optimal use of viral load testing in patients with suspected ...
OBJECTIVE: HIV treatment failure is commonly associated with drug resistance and the selection of a...
Objective: HIV treatment failure is commonly associated with drug resistance and the selection of a ...
BackgroundTo develop a predictive model to prioritize persons with a transmissible HIV viral load fo...
Objective: To develop an algorithm for optimal use of viral load testing in patients with suspected ...
Introduction:The objective of the study was to develop machine learning (ML) models that predict the...
Infections with the human immunodeficiency virus type 1 (HIV-1) are treated with combinations of dr...
BACKGROUND: The extreme flexibility of the HIV type-1 (HIV-1) genome makes it challenging to build t...
Background: Selecting the optimal combination of HIV drugs for an individual in resourcelimited sett...
BACKGROUND: The extreme flexibility of the HIV type-1 (HIV-1) genome makes it challenging to build ...
Abstract Background Treatment with effective antiretroviral therapy (ART) lowers morbidity and morta...
HIV treatment programs face challenges in identifying patients at risk for loss-to-follow-up and un...
This work shows the application of machine learning to predict current CD4 cell count of an HIV-posi...
Genotypic HIV drug-resistance testing is typically 6065 predictive of response to combination antire...
HIV viral load suppression (VLS) is the most important indicator of successful antiretroviral therap...
OBJECTIVE: To develop an algorithm for optimal use of viral load testing in patients with suspected ...
OBJECTIVE: HIV treatment failure is commonly associated with drug resistance and the selection of a...
Objective: HIV treatment failure is commonly associated with drug resistance and the selection of a ...
BackgroundTo develop a predictive model to prioritize persons with a transmissible HIV viral load fo...
Objective: To develop an algorithm for optimal use of viral load testing in patients with suspected ...
Introduction:The objective of the study was to develop machine learning (ML) models that predict the...
Infections with the human immunodeficiency virus type 1 (HIV-1) are treated with combinations of dr...